Insider Trading & Ownership - Yale Catriona

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Yale Catriona
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2024-10-30
Sale
2024-11-01
8:59 pm
Akero Therapeutics Inc.AKROYale Catriona
Chief Development Officer
20,000$32.6$651,960173,205
(Direct)
View
2024-10-14
Sale
2024-10-16
8:06 pm
Akero Therapeutics Inc.AKROYale Catriona
Chief Development Officer
20,961$30.37$636,490114,897
(Direct)
View
2024-09-20
Sale
2024-09-23
6:00 pm
Akero Therapeutics Inc.AKROYale Catriona
Chief Development Officer
5,500$27.65$152,086103,253
(Direct)
View
2024-09-16
Sale
2024-09-18
9:19 pm
Akero Therapeutics Inc.AKROYale Catriona
Chief Development Officer
8,393$27.54$231,175185,450
(Direct)
View
2024-09-10
Sale
2024-09-13
5:14 pm
Akero Therapeutics Inc.AKROYale Catriona
Chief Development Officer
637$26.18$16,67775,294
(Direct)
View
2024-09-03
Sale
2024-09-05
4:05 pm
Akero Therapeutics Inc.AKROYale Catriona
Chief Development Officer
949$27.61$26,20694,646
(Direct)
View
2024-08-23
Sale
2024-08-28
11:11 am
Akero Therapeutics Inc.AKROYale Catriona
Chief Development Officer
14,051$27.52$386,714120,459
(Direct)
View
2024-06-11
Sale
2024-06-13
6:11 pm
Akero Therapeutics Inc.AKROYale Catriona
Chief Development Officer
2,825$22.64$63,96174,867
(Direct)
View
2024-03-13
Sale
2024-03-15
4:45 pm
Akero Therapeutics Inc.AKROYale Catriona
Chief Development Officer
723$28.33$20,48377,692
(Direct)
View
2024-03-04
Sale
2024-03-06
8:13 pm
Akero Therapeutics Inc.AKROYale Catriona
Chief Development Officer
20,646$35.49$732,727167,941
(Direct)
View
2023-12-14
Sale
2023-12-18
8:49 pm
Akero Therapeutics Inc.AKROYale Catriona
Chief Development Officer
597$20.76$12,39477,910
(Direct)
View
2023-09-13
Sale
2023-09-25
8:31 pm
Akero Therapeutics Inc.AKROYale Catriona
Chief Development Officer
5,617$48.32$271,41671,182
(Direct)
View
2023-08-28
Sale
2023-08-30
7:04 pm
Akero Therapeutics Inc.AKROYale Catriona
Chief Development Officer
5,745$49.99$287,19176,799
(Direct)
View
2023-06-21
Sale
2023-06-23
8:06 pm
Akero Therapeutics Inc.AKROYale Catriona
Chief Development Officer
33,349$51.74$1,725,39046,627
(Direct)
View
2023-06-13
Sale
2023-06-15
9:29 pm
Akero Therapeutics Inc.AKROYale Catriona
Chief Development Officer
591$55.16$32,60079,976
(Direct)
View
2023-01-13
Sale
2023-01-18
5:30 pm
Akero Therapeutics Inc.AKROYale Catriona
Chief Development Officer
5,000$50.53$252,65181,268
(Direct)
View
2022-12-12
Sale
2022-12-13
8:24 pm
Akero Therapeutics Inc.AKROYale Catriona
Chief Development Officer
5,000$43.23$216,137172,647
(Direct)
View
2022-11-10
Sale
2022-11-14
5:26 pm
Akero Therapeutics Inc.AKROYale Catriona
Chief Development Officer
5,000$39.42$197,10572,073
(Direct)
View
2022-10-10
Sale
2022-10-12
4:59 pm
Akero Therapeutics Inc.AKROYale Catriona
Chief Development Officer
5,000$37.99$189,95077,073
(Direct)
View
2022-09-13
Sale
2022-09-15
7:59 pm
Akero Therapeutics Inc.AKROYale Catriona
Chief Development Officer
40,000$27.48$1,099,22882,073
(Direct)
View
2021-10-15
Sale
2021-10-18
4:21 pm
Akero Therapeutics Inc.AKROYale Catriona
Chief Development Officer
12,500$21.59$269,826120,921
(Direct)
View
2021-09-15
Sale
2021-09-17
4:05 pm
Akero Therapeutics Inc.AKROYale Catriona
Chief Development Officer
12,500$24.69$308,605133,421
(Direct)
View
2021-08-16
Sale
2021-08-17
9:15 pm
Akero Therapeutics Inc.AKROYale Catriona
Chief Development Officer
10,000$18.79$187,900145,921
(Direct)
View
2021-07-15
Sale
2021-07-19
4:43 pm
Akero Therapeutics Inc.AKROYale Catriona
Chief Development Officer
10,000$20.9$209,044155,921
(Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2024-10-30
Exercise
2024-11-01
8:59 pm
N/A
N/A
Akero Therapeutics Inc.AKROYale Catriona
Chief Development Officer
20,000$21.1173,205
(Direct)
View
2024-10-30
Exercise
2024-11-01
8:59 pm
N/A
2031-12-07
Akero Therapeutics Inc.AKROYale Catriona
Chief Development Officer
20,000$0173,205
(Direct)
View
2024-10-15
Exercise
2024-10-16
8:06 pm
N/A
N/A
Akero Therapeutics Inc.AKROYale Catriona
Chief Development Officer
19,825$0.615114,897
(Direct)
View
2024-10-15
Exercise
2024-10-16
8:06 pm
N/A
2028-09-26
Akero Therapeutics Inc.AKROYale Catriona
Chief Development Officer
19,825$0114,897
(Direct)
View
2024-09-20
Exercise
2024-09-23
6:00 pm
N/A
N/A
Akero Therapeutics Inc.AKROYale Catriona
Chief Development Officer
5,500$0.615103,253
(Direct)
View
2024-09-20
Exercise
2024-09-23
6:00 pm
N/A
2028-10-17
Akero Therapeutics Inc.AKROYale Catriona
Chief Development Officer
5,500$0103,253
(Direct)
View
2024-09-16
Exercise
2024-09-18
9:19 pm
N/A
N/A
Akero Therapeutics Inc.AKROYale Catriona
Chief Development Officer
8,393$0.615185,450
(Direct)
View
2024-09-16
Exercise
2024-09-18
9:19 pm
N/A
2028-10-17
Akero Therapeutics Inc.AKROYale Catriona
Chief Development Officer
8,393$0185,450
(Direct)
View
2024-09-03
Exercise
2024-09-05
4:05 pm
N/A
N/A
Akero Therapeutics Inc.AKROYale Catriona
Chief Development Officer
949$0.61594,646
(Direct)
View
2024-09-03
Exercise
2024-09-05
4:05 pm
N/A
2028-09-26
Akero Therapeutics Inc.AKROYale Catriona
Chief Development Officer
949$094,646
(Direct)
View
2024-08-23
Exercise
2024-08-28
11:11 am
N/A
N/A
Akero Therapeutics Inc.AKROYale Catriona
Chief Development Officer
14,051$0.615120,459
(Direct)
View
2024-08-23
Exercise
2024-08-28
11:11 am
N/A
2028-09-26
Akero Therapeutics Inc.AKROYale Catriona
Chief Development Officer
14,051$0120,459
(Direct)
View
2024-06-28
Option Award
2024-07-02
6:56 pm
N/A
N/A
Akero Therapeutics Inc.AKROYale Catriona
Chief Development Officer
1,064$19.9475,931
(Direct)
View
2024-03-04
Exercise
2024-03-06
8:13 pm
N/A
N/A
Akero Therapeutics Inc.AKROYale Catriona
Chief Development Officer
10,646$21.09167,941
(Direct)
View
2024-03-04
Exercise
2024-03-06
8:13 pm
N/A
N/A
Akero Therapeutics Inc.AKROYale Catriona
Chief Development Officer
10,000$6.36167,941
(Direct)
View
2024-03-04
Exercise
2024-03-06
8:13 pm
N/A
2029-01-15
Akero Therapeutics Inc.AKROYale Catriona
Chief Development Officer
20,646$0167,941
(Direct)
View
2023-12-08
Option Award
2023-12-12
4:26 pm
N/A
2033-12-07
Akero Therapeutics Inc.AKROYale Catriona
Chief Development Officer
178,734$0224,744
(Direct)
View
2023-09-21
Exercise
2023-09-25
8:31 pm
N/A
N/A
Akero Therapeutics Inc.AKROYale Catriona
Chief Development Officer
5,000$6.3671,182
(Direct)
View
2023-09-21
Exercise
2023-09-25
8:31 pm
N/A
2029-01-15
Akero Therapeutics Inc.AKROYale Catriona
Chief Development Officer
5,000$071,182
(Direct)
View
2023-08-28
Exercise
2023-08-30
7:04 pm
N/A
N/A
Akero Therapeutics Inc.AKROYale Catriona
Chief Development Officer
5,745$6.3676,799
(Direct)
View
2023-08-28
Exercise
2023-08-30
7:04 pm
N/A
2029-01-15
Akero Therapeutics Inc.AKROYale Catriona
Chief Development Officer
5,745$076,799
(Direct)
View
2023-03-10
Tax Withholding
2023-03-14
4:20 pm
N/A
N/A
Akero Therapeutics Inc.AKROYale Catriona
Chief Development Officer
701$43.4680,567
(Direct)
View
2022-12-16
Option Award
2022-12-20
7:52 pm
N/A
2031-12-07
Akero Therapeutics Inc.AKROYale Catriona
Chief Development Officer
29,073$087,221
(Direct)
View
2022-12-09
Option Award
2022-12-13
8:24 pm
N/A
2032-12-08
Akero Therapeutics Inc.AKROYale Catriona
Chief Development Officer
105,574$0172,647
(Direct)
View
2022-09-09
Option Award
2022-09-13
9:15 pm
N/A
2031-12-07
Akero Therapeutics Inc.AKROYale Catriona
Chief Development Officer
58,148$0209,295
(Direct)
View
2022-06-30
Option Award
2022-09-13
9:15 pm
N/A
N/A
Akero Therapeutics Inc.AKROYale Catriona
Chief Development Officer
1,152$8.03209,295
(Direct)
View
2021-12-08
Option Award
2021-12-10
5:08 pm
N/A
2031-12-07
Akero Therapeutics Inc.AKROYale Catriona
Chief Development Officer
87,221$087,221
(Direct)
View
2020-12-08
Option Award
2020-12-09
8:50 pm
N/A
2030-12-07
Akero Therapeutics Inc.AKROYale Catriona
Chief Development Officer
77,580$0242,494
(Direct)
View
2020-06-30
Option Award
2020-12-09
8:50 pm
N/A
N/A
Akero Therapeutics Inc.AKROYale Catriona
Chief Development Officer
1,245$17.07242,494
(Direct)
View
2019-12-31
Option Award
2020-01-03
6:16 pm
N/A
N/A
Akero Therapeutics Inc.AKROYale Catriona
Chief Development Officer
1,025$18.87163,669
(Direct)
View
2019-12-13
Option Award
2019-12-13
9:06 pm
N/A
2029-12-12
Akero Therapeutics Inc.AKROYale Catriona
Chief Development Officer
85,000$085,000
(Direct)
View